ANNA LARK: Open Payments
NPI 1508646688 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,077 in 65 payments from 23 companies in 2025. Trend: 2023 $14 · 2024 $1,268 · 2025 $1,077
Food & beverage: $1,077
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $206 |
| GlaxoSmithKline, LLC. | 9 | $150 |
| PFIZER INC. | 7 | $114 |
| AstraZeneca Pharmaceuticals LP | 7 | $107 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $56 |
| Daiichi Sankyo Inc. | 2 | $53 |
| Astellas Pharma US Inc | 2 | $38 |
| Dexcom, Inc. | 2 | $36 |
| ABBVIE INC. | 2 | $31 |
| Amgen Inc. | 2 | $30 |
Products named: TRELEGY ELLIPTA, Ozempic, Wegovy, PREVNAR 20, XIFAXAN, INJECTAFER, FARXIGA, Veozah.
Industry payments across SC — which companies pay providers there.
